Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis

References

• Alangari AA. 2010. Genomic and non-genomic actions of glucocorticoids in asthma. Ann Thorac Med. 5(3):133–39.
   PubMed Web of Science ®Google Scholar
• Angeli A, Frajria R, Bisbocci D, Ceresa F. 1977. Temporal changes in plasma transcortin (cbg) binding capacity during the menstrual cycle. Biol Rhythm Res. 8(3–4):237–42.
   Web of Science ®Google Scholar
• Arlt W, Stewart PM. 2005. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am. 34(2):293–313, viii.
   PubMed Web of Science ®Google Scholar
• Bae S-A, Androulakis IP. 2017. The synergistic role of light-feeding phase relations on entraining robust circadian rhythms in the periphery. Gene Regul Syst Bio. 11:1177625017702393.
   Web of Science ®Google Scholar
• Ballesta A, Innominato PF, Dallmann R, Rand DA, Levi FA. 2017. Systems chronotherapeutics. Pharmacol Rev. 69(2):161–99.
   PubMed Web of Science ®Google Scholar
• Beltrametti SP, Ianniello A, Ricci C. 2016. Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: A review. Ther Clin Risk Manag. 12:1763–76.
   PubMed Web of Science ®Google Scholar
• Bodick N, Lufkin J, Willwerth C, Kumar A, Bolognese J, Schoonmaker C, Ballal R, Hunter D, Clayman M. 2015. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: A randomized clinical trial. J Bone Joint Surg Am. 97(11):877–88.
   PubMed Web of Science ®Google Scholar
• Bordyugov G, Abraham U, Granada A, Rose P, Imkeller K, Kramer A, Herzel H. 2015. Tuning the phase of circadian entrainment. J R Soc Interface. 12(108):20150282.
   PubMed Web of Science ®Google Scholar
• Buijs RM, van Eden CG, Goncharuk VD, Kalsbeek A. 2003. The biological clock tunes the organs of the body: Timing by hormones and the autonomic nervous system. J Endocrinol. 177(1):17–26.
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Burmester GR, Lipworth BJ. 2005. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet. 365(9461):801–03.
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, Supronik J, Szombati I, Romer U, Witte S, et al. 2013. Low-dose prednisone chronotherapy for rheumatoid arthritis: A randomised clinical trial (capra-2). Ann Rheum Dis. 72(2):204–10.
   PubMed Web of Science ®Google Scholar
• Cirincione B, Edwards J, Mager DE. 2017. Population pharmacokinetics of an extended-release formulation of exenatide following single- and multiple-dose administration. AAPS J. 19(2):487–96.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG. 2006. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 55(3):420–26.
   PubMed Web of Science ®Google Scholar
• Cutolo M. 2016. Glucocorticoids and chronotherapy in rheumatoid arthritis. RMD Open. 2(1):e000203.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B. 2005. Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease’s symptoms. Autoimmun Rev. 4(8):497–502.
   PubMed Web of Science ®Google Scholar
• Czock D, Keller F, Rasche FM, Haussler U. 2005. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 44(1):61–98.
   PubMed Web of Science ®Google Scholar
• Dibner C, Schibler U, Albrecht U. 2010. The mammalian circadian timing system: Organization and coordination of central and peripheral clocks. Annu Rev Physiol. 72:517–49.
   PubMed Web of Science ®Google Scholar
• Ebner K, Singewald N. 2017. Individual differences in stress susceptibility and stress inhibitory mechanisms. Curr Opin Behav Sci. 14:54–64.
   Web of Science ®Google Scholar
• Edwards C. 2012. Sixty years after hench–corticosteroids and chronic inflammatory disease. J Clin Endocrinol Metab. 97(5):1443–51.
   PubMed Web of Science ®Google Scholar
• Fardet L, Petersen I, Nazareth I. 2012. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 169(5):491–97.
   PubMed Web of Science ®Google Scholar
• Fietta P, Fietta P, Delsante G. 2009. Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci. 63(5):613–22.
   PubMed Web of Science ®Google Scholar
• Fisher LE, Ludwig EA, Wald JA, Sloan RR, Middleton E Jr., Jusko WJ. 1992. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther. 51(6):677–88.
   PubMed Web of Science ®Google Scholar
• Forss M, Batcheller G, Skrtic S, Johannsson G. 2012. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord. 12:8.
   PubMed Web of Science ®Google Scholar
• Goodwin BC. 1965. Oscillatory behavior in enzymatic control processes. Adv Enzyme Regul. 3:425–38.
   PubMedGoogle Scholar
• Harris AP, Holmes MC, de Kloet ER, Chapman KE, Seckl JR. 2013. Mineralocorticoid and glucocorticoid receptor balance in control of hpa axis and behaviour. Psychoneuroendocrinology. 38(5):648–58.
   PubMed Web of Science ®Google Scholar
• Hartmanshenn C, Scherholz M, Androulakis IP. 2016. Physiologically-based pharmacokinetic models: Approaches for enabling personalized medicine. J Pharmacokinet Pharmacodyn. 43(5):481–504.
   PubMed Web of Science ®Google Scholar
• Haus E, Sackett-Lundeen L, Smolensky MH. 2012. Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications. Bull NYU Hosp Jt Dis. 70(Suppl 1):3–10.
   PubMedGoogle Scholar
• Hench PS, Kendall EC, Slocumb CH, Polley HF. 1949. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound e) and of pituitary adrenocortical hormone in arthritis: preliminary report. Ann Rheum Dis. 8(2):97–104.
   PubMed Web of Science ®Google Scholar
• Hwang JL, Weiss RE. 2014. Steroid-induced diabetes: A clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 30(2):96–102.
   PubMed Web of Science ®Google Scholar
• Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S. 2009. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: A pharmacokinetic study. Eur J Endocrinol. 161(1):119–30.
   PubMed Web of Science ®Google Scholar
• Johnson CH. 1992. Phase response curves: what can they tell us about circadian clocks. Circadian clocks from cell to human. Sapporo, Japan: Hokkaido University Press. p.209–49
   Google Scholar
• Jung CM, Khalsa SB, Scheer FA, Cajochen C, Lockley SW, Czeisler CA, Wright KP Jr. 2010. Acute effects of bright light exposure on cortisol levels. J Biol Rhythms. 25(3):208–16.
   PubMed Web of Science ®Google Scholar
• Kalsbeek A, Fliers E, Hofman MA, Swaab DF, Buijs RM. 2010. Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol. 22(5):362–72.
   PubMed Web of Science ®Google Scholar
• Kirwan JR. 2011. Targeting the time of day for glucocorticoid delivery in rheumatoid arthritis. Int J Clin Rheumatol. 6(3):273–79.
   Google Scholar
• Kirwan JR, Clarke L, Hunt LP, Perry MG, Straub RH, Jessop DS. 2010. Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis. Ann NY Acad Sci. 1193:127–33.
   PubMed Web of Science ®Google Scholar
• Kouri V-P, Olkkonen J, Kaivosoja E, Ainola M, Juhila J, Hovatta I, Konttinen YT, Mandelin J. 2013. Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level. PLoS ONE. 8(1). doi:10.1371/journal.pone.0054049
   Web of Science ®Google Scholar
• Levi F, Schibler U. 2007. Circadian rhythms: Mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 47(1):593–628.
   PubMedGoogle Scholar
• Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H. 2013. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 9(1):30.
   PubMedGoogle Scholar
• Magee MH, Blum RA, Lates CD, Jusko WJ. 2001. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol. 41(11):1180–94.
   PubMed Web of Science ®Google Scholar
• Malisch JL, Breuner CW, Gomes FR, Chappell MA, Garland T Jr. 2008. Circadian pattern of total and free corticosterone concentrations, corticosteroid-binding globulin, and physical activity in mice selectively bred for high voluntary wheel-running behavior. Gen Comp Endocrinol. 156(2):210–17.
   PubMed Web of Science ®Google Scholar
• Markovic VM, Cupic Z, Vukojevic V, Kolar-Anic L. 2011. Predictive modeling of the hypothalamic-pituitary-adrenal (hpa) axis response to acute and chronic stress. Endocr J. 58(10):889–904.
   PubMed Web of Science ®Google Scholar
• Mavroudis PD, Corbett SA, Calvano SE, Androulakis IP. 2014. Mathematical modeling of light-mediated hpa axis activity and downstream implications on the entrainment of peripheral clock genes. Physiol Genomics. 46(20):766–78.
   PubMed Web of Science ®Google Scholar
• McMaster A, Ray DW. 2007. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects. Exp Physiol. 92(2):299–309.
   PubMed Web of Science ®Google Scholar
• Moghadam‐Kia S, Werth VP. 2010. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol. 49(3):239–48.
   PubMed Web of Science ®Google Scholar
• Mould DR, Upton RN. 2013. Basic concepts in population modeling, simulation, and model-based drug development-part 2: Introduction to pharmacokinetic modeling methods. CPT Pharmacometrics Syst Pharmacol. 2:e38.
   PubMedGoogle Scholar
• Newell-Price J, Whiteman M, Rostami-Hodjegan A, Darzy K, Shalet S, Tucker GT, Ross RJ. 2008. Modified-release hydrocortisone for circadian therapy: A proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf). 68(1):130–35.
   PubMed Web of Science ®Google Scholar
• Nicolaides NC, Charmandari E, Kino T, Chrousos GP. 2017. Stress-related and circadian secretion and target tissue actions of glucocorticoids: Impact on health. Front Endocrinol (Lausanne). 8:70.
   PubMed Web of Science ®Google Scholar
• Ohdo S, Koyanagi S, Matsunaga N. 2010. Chronopharmacological strategies: Intra- and inter-individual variability of molecular clock. Adv Drug Deliv Rev. 62(9–10):885–97.
   PubMed Web of Science ®Google Scholar
• Oster H, Challet E, Ott V, Arvat E, Ronald de Kloet E, Dijk DJ, Lightman S, Vgontzas A, Van Cauter E. 2017. The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr Rev. 38(1):3–45.
   PubMed Web of Science ®Google Scholar
• Peng HT, Bouak F, Vartanian O, Cheung B. 2013. A physiologically based pharmacokinetics model for melatonin–effects of light and routes of administration. Int J Pharm. 458(1):156–68.
   PubMedGoogle Scholar
• Pierre K, Schlesinger N, Androulakis IP. 2016. The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity. Physiol Genomics. 48(10):719–38.
   PubMed Web of Science ®Google Scholar
• Pierre K, Schlesinger N, Androulakis IP. 2017. The hepato-hypothalamic-pituitary-adrenal-renal axis: Mathematical modeling of cortisol’s production, metabolism and seasonal variation. J Biol Rhythms. 32:469–84. In Press. doi:10.1177/0748730417729929.
   PubMed Web of Science ®Google Scholar
• Potter GD, Skene DJ, Arendt J, Cade JE, Grant PJ, Hardie LJ. 2016. Circadian rhythm and sleep disruption: Causes, metabolic consequences, and countermeasures. Endocr Rev. 37(6):584–608.
   PubMed Web of Science ®Google Scholar
• Pulivarthy SR, Tanaka N, Welsh DK, De Haro L, Verma IM, Panda S. 2007. Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock. Proc Natl Acad Sci USA. 104(51):20356–61.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. 2002. Fifth-generation model for corticosteroid pharmacodynamics: Application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats. J Pharmacokinet Pharmacodyn. 29(1):1–24.
   PubMed Web of Science ®Google Scholar
• Rao R, DuBois D, Almon R, Jusko WJ, Androulakis IP. 2016. Mathematical modeling of the circadian dynamics of the neuroendocrine-immune network in experimentally induced arthritis. Am J Physiol Endocrinol Metab. 311(2):E310–324.
   PubMed Web of Science ®Google Scholar
• Rao RT, Androulakis IP. 2017. Modeling the sex differences and interindividual variability in the activity of the hypothalamic-pituitary-adrenal axis. Endocrinology. 158(11):4017–37.
   PubMed Web of Science ®Google Scholar
• Rhen T, Cidlowski JA. 2005. Antiinflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med. 353(16):1711–23.
   PubMed Web of Science ®Google Scholar
• Schmal C, Myung J, Herzel H, Bordyugov G. 2015. A theoretical study on seasonality. Front Neurol. 6:94.
   PubMed Web of Science ®Google Scholar
• Smith SM, Vale WW. 2006. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 8(4):383–95.
   PubMedGoogle Scholar
• Smolensky MH, Peppas NA. 2007. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 59(9–10):828–51.
   PubMedGoogle Scholar
• Spiga F, Walker JJ, Terry JR, Lightman SL. 2014. Hpa axis-rhythms. In Terjung R, editor. Comprehensive physiology. Hoboken (NJ): John Wiley & Sons, Inc; p. 1273–98.
   Google Scholar
• Spoelstra K, Albrecht U, van der Horst GT, Brauer V, Daan S. 2004. Phase responses to light pulses in mice lacking functional per or cry genes. J Biol Rhythms. 19(6):518–29.
   PubMed Web of Science ®Google Scholar
• Sriram K, Rodriguez-Fernandez M, Doyle FJ. 2012. Modeling cortisol dynamics in the neuro-endocrine axis distinguishes normal, depression, and post-traumatic stress disorder (ptsd) in humans. PLoS Comput Biol. 8(2). doi:10.1371/journal.pcbi.1002379
   PubMed Web of Science ®Google Scholar
• Sukumaran S, Almon RR, DuBois DC, Jusko WJ. 2010. Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action. Adv Drug Deliv Rev. 62(9–10):904–17.
   PubMed Web of Science ®Google Scholar
• Xu J, Winkler J, Derendorf H. 2007. A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma. J Pharmacokinet Pharmacodyn. 34(3):355–72.
   PubMed Web of Science ®Google Scholar
• Xu J, Winkler J, Sabarinath SN, Derendorf H. 2008. Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone. AAPS J. 10(2):331–41.
   PubMed Web of Science ®Google Scholar